| |
 |
|
Class Information
Number: 514/11
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > Cyclopeptides > Monocyclic
Description: Subject matter wherein a compound has only one cyclic group containing an amino acid chain.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6713452 |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
Mar. 30, 2004 |
| 6710029 |
Dehydrodidemnin B |
Mar. 23, 2004 |
| 6699467 |
Compounds and compositions for delivering active agents |
Mar. 2, 2004 |
| 6696412 |
High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
Feb. 24, 2004 |
| 6696409 |
Neuropeptide Y agonists |
Feb. 24, 2004 |
| 6696413 |
Pharmaceutical preparation with cyclosporin A |
Feb. 24, 2004 |
| 6693073 |
Pulmonary delivery of active agents |
Feb. 17, 2004 |
| 6683048 |
Compounds and methods for stimulating gene expression and cellular differentiation |
Jan. 27, 2004 |
| 6677376 |
Non-peptidic cyclophilin binding compounds and their use |
Jan. 13, 2004 |
| 6676931 |
Buccal, polar and non-polar spray or capsule |
Jan. 13, 2004 |
| 6673769 |
Lanthionine bridged peptides |
Jan. 6, 2004 |
| 6673771 |
Methods of inhibiting osteoclast activity |
Jan. 6, 2004 |
| 6673768 |
Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
Jan. 6, 2004 |
| 6669951 |
Compositions and methods for enhancing drug delivery across and into epithelial tissues |
Dec. 30, 2003 |
| 6656905 |
Cyclic tetrapeptide compound and use thereof |
Dec. 2, 2003 |
| 6656504 |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
Dec. 2, 2003 |
| 6653281 |
Ring modified cyclic peptide analogs |
Nov. 25, 2003 |
| 6645509 |
Polypeptide expressed in the horny layer of epidermis and use thereof |
Nov. 11, 2003 |
| 6632456 |
Compositions for inhalation |
Oct. 14, 2003 |
| 6630447 |
Peptide inhibitors of LFA-1/ICAM-1 interaction |
Oct. 7, 2003 |
| 6630147 |
Pseudomycin natural products |
Oct. 7, 2003 |
| 6623731 |
Compounds and compositions for delivering active agents |
Sep. 23, 2003 |
| 6624144 |
Matrix metalloproteinase inhibitors and down-regulators |
Sep. 23, 2003 |
| 6620782 |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
Sep. 16, 2003 |
| 6617345 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
Sep. 9, 2003 |
| 6613739 |
Deuterated cyclosporine analogs and their use as immunomodulating agents |
Sep. 2, 2003 |
| 6613734 |
Peptides-containing liposomal surfactants |
Sep. 2, 2003 |
| 6610655 |
Pentapeptide with specific conformation, its production and use |
Aug. 26, 2003 |
| 6610735 |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
Aug. 26, 2003 |
| 6608028 |
Insulin-like growth factor agonist molecules |
Aug. 19, 2003 |
| 6608027 |
Macrocyclic peptides active against the hepatitis C virus |
Aug. 19, 2003 |
| 6605593 |
Deuterated cyclosporine analogs and their use as immunomodulating agents |
Aug. 12, 2003 |
| 6602849 |
Cyclic somatostatin analogs |
Aug. 5, 2003 |
| 6596268 |
Viruses for the treatment of cellular proliferative disorders |
Jul. 22, 2003 |
| 6593297 |
Compounds and methods for inhibiting cancer metastasis |
Jul. 15, 2003 |
| 6593292 |
Compositions and methods for enhancing drug delivery across and into epithelial tissues |
Jul. 15, 2003 |
| 6583114 |
Fracture healing using pthrp analogs |
Jun. 24, 2003 |
| 6565831 |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
May. 20, 2003 |
| 6566327 |
Histogranin peptides and their analgesic use |
May. 20, 2003 |
| 6565859 |
Galenical formulations |
May. 20, 2003 |
| 6562786 |
Compounds and methods for modulating apoptosis |
May. 13, 2003 |
| 6555126 |
Method for treating, controlling, and preventing Diabetes Mellitus |
Apr. 29, 2003 |
| 6551994 |
Compounds and methods for inhibiting the interaction between .alpha.-catenin and .beta.-catenin |
Apr. 22, 2003 |
| 6548527 |
Treatments for immune-mediated ear disorders |
Apr. 15, 2003 |
| 6541450 |
Parathyroid hormone analogues for the treatment of osteoporosis |
Apr. 1, 2003 |
| 6541451 |
Streptogramin derivatives, their preparation and compositions containing them |
Apr. 1, 2003 |
| 6531139 |
Self-emulsifying formulation for lipophilic compounds |
Mar. 11, 2003 |
| 6525022 |
Receptor specific atrial natriuretic peptides |
Feb. 25, 2003 |
| 6521595 |
Nonimmunosuppressive [.gamma.-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same |
Feb. 18, 2003 |
| 6521599 |
Stable pharmaceutical formulation for intravenous or intramuscular administration of active peptide compounds |
Feb. 18, 2003 |
|
|
|
